APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atezolizumab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Atezolizumab Market Analysis and Forecast 2026-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchAtezolizumab Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Atezolizumab Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Atezolizumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atezolizumab Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Atezolizumab Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Atezolizumab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Atezolizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Atezolizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Atezolizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Atezolizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Atezolizumab include Genentech (Roche). etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Atezolizumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Atezolizumab, also provides the sales of main regions and countries. Of the upcoming market potential for Atezolizumab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atezolizumab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Atezolizumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Atezolizumab sales, projected growth trends, production technology, application and end-user industry.

Atezolizumab Segment by Company

Genentech (Roche)

Atezolizumab Segment by Type

Use: Single Drug

Use: ChemOthersapy Combination

Atezolizumab Segment by Application

Advanced Triple-negative Breast Cancer

Head and Neck Cancer

Renal Cell Carcinoma

Urothelial Carcinoma

Hepatocellular Carcinoma (HCC)

Lung Cancer

Bladder Cancer

Others

Atezolizumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atezolizumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atezolizumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atezolizumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Atezolizumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Atezolizumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atezolizumab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Atezolizumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Use: Single Drug Major Manufacturers Table 3. Use: ChemOthersapy Combination Major Manufacturers Table 4. Global Atezolizumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Advanced Triple-negative Breast Cancer Major Manufacturers Table 6. Head and Neck Cancer Major Manufacturers Table 7. Renal Cell Carcinoma Major Manufacturers Table 8. Urothelial Carcinoma Major Manufacturers Table 9. Hepatocellular Carcinoma (HCC) Major Manufacturers Table 10. Lung Cancer Major Manufacturers Table 11. Bladder Cancer Major Manufacturers Table 12. Others Major Manufacturers Table 13. Atezolizumab Industry Trends Table 14. Atezolizumab Industry Drivers Table 15. Atezolizumab Industry Opportunities and Challenges Table 16. Atezolizumab Industry Restraints Table 17. Global Atezolizumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Atezolizumab Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Atezolizumab Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Atezolizumab Revenue Market Share by Region (2021-2026) Table 21. Global Atezolizumab Revenue Market Share by Region (2027-2032) Table 22. Global Atezolizumab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 23. Global Atezolizumab Sales by Region (2021-2026) & (k units) Table 24. Global Atezolizumab Sales by Region (2027-2032) & (k units) Table 25. Global Atezolizumab Sales Market Share by Region (2021-2026) Table 26. Global Atezolizumab Sales Market Share by Region (2027-2032) Table 27. Global Atezolizumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Atezolizumab Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Atezolizumab Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Atezolizumab Sales Market Share by Manufacturers (2021-2026) Table 31. Global Atezolizumab Sales Price (US$/unit) of Manufacturers (2021-2026) Table 32. Global Atezolizumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Atezolizumab Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Atezolizumab Manufacturers, Product Type & Application Table 35. Global Atezolizumab Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Atezolizumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Atezolizumab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Atezolizumab Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Atezolizumab Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Atezolizumab Revenue Market Share by Type (2021-2026) Table 42. Global Atezolizumab Revenue Market Share by Type (2027-2032) Table 43. Global Atezolizumab Sales by Type 2021 VS 2025 VS 2032 (k units) Table 44. Global Atezolizumab Sales by Type (2021-2026) & (k units) Table 45. Global Atezolizumab Sales by Type (2027-2032) & (k units) Table 46. Global Atezolizumab Sales Market Share by Type (2021-2026) Table 47. Global Atezolizumab Sales Market Share by Type (2027-2032) Table 48. Global Atezolizumab Price by Type (2021-2026) & (US$/unit) Table 49. Global Atezolizumab Price by Type (2027-2032) & (US$/unit) Table 50. Global Atezolizumab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Atezolizumab Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Atezolizumab Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Atezolizumab Revenue Market Share by Application (2021-2026) Table 54. Global Atezolizumab Revenue Market Share by Application (2027-2032) Table 55. Global Atezolizumab Sales by Application 2021 VS 2025 VS 2032 (k units) Table 56. Global Atezolizumab Sales by Application (2021-2026) & (k units) Table 57. Global Atezolizumab Sales by Application (2027-2032) & (k units) Table 58. Global Atezolizumab Sales Market Share by Application (2021-2026) Table 59. Global Atezolizumab Sales Market Share by Application (2027-2032) Table 60. Global Atezolizumab Price by Application (2021-2026) & (US$/unit) Table 61. Global Atezolizumab Price by Application (2027-2032) & (US$/unit) Table 62. Genentech (Roche) Company Information Table 63. Genentech (Roche) Business Overview Table 64. Genentech (Roche) Atezolizumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Genentech (Roche) Atezolizumab Product Portfolio Table 66. Genentech (Roche) Recent Development Table 67. North America Atezolizumab Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Atezolizumab Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Atezolizumab Sales by Type (2021-2026) & (k units) Table 70. North America Atezolizumab Sales by Type (2027-2032) & (k units) Table 71. North America Atezolizumab Sales Price by Type (2021-2026) & (US$/unit) Table 72. North America Atezolizumab Sales Price by Type (2027-2032) & (US$/unit) Table 73. North America Atezolizumab Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Atezolizumab Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Atezolizumab Sales by Application (2021-2026) & (k units) Table 76. North America Atezolizumab Sales by Application (2027-2032) & (k units) Table 77. North America Atezolizumab Sales Price by Application (2021-2026) & (US$/unit) Table 78. North America Atezolizumab Sales Price by Application (2027-2032) & (US$/unit) Table 79. North America Atezolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Atezolizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Atezolizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Atezolizumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 83. North America Atezolizumab Sales by Country (2021-2026) & (k units) Table 84. North America Atezolizumab Sales by Country (2027-2032) & (k units) Table 85. North America Atezolizumab Sales Price by Country (2021-2026) & (US$/unit) Table 86. North America Atezolizumab Sales Price by Country (2027-2032) & (US$/unit) Table 87. United States Atezolizumab Revenue (2021-2032) & (US$ Million) Table 88. Canada Atezolizumab Revenue (2021-2032) & (US$ Million) Table 89. Mexico Atezolizumab Revenue (2021-2032) & (US$ Million) Table 90. Europe Atezolizumab Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Atezolizumab Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Atezolizumab Sales by Type (2021-2026) & (k units) Table 93. Europe Atezolizumab Sales by Type (2027-2032) & (k units) Table 94. Europe Atezolizumab Sales Price by Type (2021-2026) & (US$/unit) Table 95. Europe Atezolizumab Sales Price by Type (2027-2032) & (US$/unit) Table 96. Europe Atezolizumab Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Atezolizumab Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Atezolizumab Sales by Application (2021-2026) & (k units) Table 99. Europe Atezolizumab Sales by Application (2027-2032) & (k units) Table 100. Europe Atezolizumab Sales Price by Application (2021-2026) & (US$/unit) Table 101. Europe Atezolizumab Sales Price by Application (2027-2032) & (US$/unit) Table 102. Europe Atezolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Atezolizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Atezolizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Atezolizumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 106. Europe Atezolizumab Sales by Country (2021-2026) & (k units) Table 107. Europe Atezolizumab Sales by Country (2027-2032) & (k units) Table 108. Europe Atezolizumab Sales Price by Country (2021-2026) & (US$/unit) Table 109. Europe Atezolizumab Sales Price by Country (2027-2032) & (US$/unit) Table 110. Germany Atezolizumab Revenue (2021-2032) & (US$ Million) Table 111. France Atezolizumab Revenue (2021-2032) & (US$ Million) Table 112. U.K. Atezolizumab Revenue (2021-2032) & (US$ Million) Table 113. Italy Atezolizumab Revenue (2021-2032) & (US$ Million) Table 114. Russia Atezolizumab Revenue (2021-2032) & (US$ Million) Table 115. Spain Atezolizumab Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Atezolizumab Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Atezolizumab Revenue (2021-2032) & (US$ Million) Table 118. Sweden Atezolizumab Revenue (2021-2032) & (US$ Million) Table 119. Poland Atezolizumab Revenue (2021-2032) & (US$ Million) Table 120. China Atezolizumab Revenue by Type (2021-2026) & (US$ Million) Table 121. China Atezolizumab Revenue by Type (2027-2032) & (US$ Million) Table 122. China Atezolizumab Sales by Type (2021-2026) & (k units) Table 123. China Atezolizumab Sales by Type (2027-2032) & (k units) Table 124. China Atezolizumab Sales Price by Type (2021-2026) & (US$/unit) Table 125. China Atezolizumab Sales Price by Type (2027-2032) & (US$/unit) Table 126. China Atezolizumab Revenue by Application (2021-2026) & (US$ Million) Table 127. China Atezolizumab Revenue by Application (2027-2032) & (US$ Million) Table 128. China Atezolizumab Sales by Application (2021-2026) & (k units) Table 129. China Atezolizumab Sales by Application (2027-2032) & (k units) Table 130. China Atezolizumab Sales Price by Application (2021-2026) & (US$/unit) Table 131. China Atezolizumab Sales Price by Application (2027-2032) & (US$/unit) Table 132. Asia Atezolizumab Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Atezolizumab Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Atezolizumab Sales by Type (2021-2026) & (k units) Table 135. Asia Atezolizumab Sales by Type (2027-2032) & (k units) Table 136. Asia Atezolizumab Sales Price by Type (2021-2026) & (US$/unit) Table 137. Asia Atezolizumab Sales Price by Type (2027-2032) & (US$/unit) Table 138. Asia Atezolizumab Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Atezolizumab Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Atezolizumab Sales by Application (2021-2026) & (k units) Table 141. Asia Atezolizumab Sales by Application (2027-2032) & (k units) Table 142. Asia Atezolizumab Sales Price by Application (2021-2026) & (US$/unit) Table 143. Asia Atezolizumab Sales Price by Application (2027-2032) & (US$/unit) Table 144. Asia Atezolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Atezolizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Atezolizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Atezolizumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. Asia Atezolizumab Sales by Country (2021-2026) & (k units) Table 149. Asia Atezolizumab Sales by Country (2027-2032) & (k units) Table 150. Asia Atezolizumab Sales Price by Country (2021-2026) & (US$/unit) Table 151. Asia Atezolizumab Sales Price by Country (2027-2032) & (US$/unit) Table 152. Japan Atezolizumab Revenue (2021-2032) & (US$ Million) Table 153. South Korea Atezolizumab Revenue (2021-2032) & (US$ Million) Table 154. India Atezolizumab Revenue (2021-2032) & (US$ Million) Table 155. Australia Atezolizumab Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Atezolizumab Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Atezolizumab Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Atezolizumab Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Atezolizumab Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Atezolizumab Sales by Type (2021-2026) & (k units) Table 161. SAMEA Atezolizumab Sales by Type (2027-2032) & (k units) Table 162. SAMEA Atezolizumab Sales Price by Type (2021-2026) & (US$/unit) Table 163. SAMEA Atezolizumab Sales Price by Type (2027-2032) & (US$/unit) Table 164. SAMEA Atezolizumab Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Atezolizumab Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Atezolizumab Sales by Application (2021-2026) & (k units) Table 167. SAMEA Atezolizumab Sales by Application (2027-2032) & (k units) Table 168. SAMEA Atezolizumab Sales Price by Application (2021-2026) & (US$/unit) Table 169. SAMEA Atezolizumab Sales Price by Application (2027-2032) & (US$/unit) Table 170. SAMEA Atezolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Atezolizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Atezolizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Atezolizumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. SAMEA Atezolizumab Sales by Country (2021-2026) & (k units) Table 175. SAMEA Atezolizumab Sales by Country (2027-2032) & (k units) Table 176. SAMEA Atezolizumab Sales Price by Country (2021-2026) & (US$/unit) Table 177. SAMEA Atezolizumab Sales Price by Country (2027-2032) & (US$/unit) Table 178. Brazil Atezolizumab Revenue (2021-2032) & (US$ Million) Table 179. Argentina Atezolizumab Revenue (2021-2032) & (US$ Million) Table 180. Chile Atezolizumab Revenue (2021-2032) & (US$ Million) Table 181. Colombia Atezolizumab Revenue (2021-2032) & (US$ Million) Table 182. Peru Atezolizumab Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Atezolizumab Revenue (2021-2032) & (US$ Million) Table 184. Israel Atezolizumab Revenue (2021-2032) & (US$ Million) Table 185. UAE Atezolizumab Revenue (2021-2032) & (US$ Million) Table 186. Turkey Atezolizumab Revenue (2021-2032) & (US$ Million) Table 187. Iran Atezolizumab Revenue (2021-2032) & (US$ Million) Table 188. Egypt Atezolizumab Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Atezolizumab Distributors List Table 192. Atezolizumab Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Atezolizumab Image Figure 2. Global Atezolizumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atezolizumab Market Size Share 2021 VS 2025 VS 2032 Figure 4. Use: Single Drug Image Figure 5. Use: ChemOthersapy Combination Image Figure 6. Global Atezolizumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Atezolizumab Market Size Share 2021 VS 2025 VS 2032 Figure 8. Advanced Triple-negative Breast Cancer Image Figure 9. Head and Neck Cancer Image Figure 10. Renal Cell Carcinoma Image Figure 11. Urothelial Carcinoma Image Figure 12. Hepatocellular Carcinoma (HCC) Image Figure 13. Lung Cancer Image Figure 14. Bladder Cancer Image Figure 15. Others Image Figure 16. Global Atezolizumab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Atezolizumab Revenue (2021-2032) & (US$ Million) Figure 18. Global Atezolizumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Atezolizumab Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Atezolizumab Revenue Market Share by Region (2021-2032) Figure 21. Global Atezolizumab Sales (2021-2032) & (k units) Figure 22. Global Atezolizumab Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 23. Global Atezolizumab Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Atezolizumab Sales YoY (2021-2032) & (k units) Figure 25. Europe Atezolizumab Sales YoY (2021-2032) & (k units) Figure 26. China Atezolizumab Sales YoY (2021-2032) & (k units) Figure 27. Asia (Excluding China) Atezolizumab Sales YoY (2021-2032) & (k units) Figure 28. South America, Middle East and Africa Atezolizumab Sales YoY (2021-2032) & (k units) Figure 29. Global Atezolizumab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Atezolizumab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Atezolizumab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Atezolizumab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Atezolizumab Revenue Market Share by Type (2021-2032) Figure 35. Global Atezolizumab Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Atezolizumab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Atezolizumab Sales Market Share by Type (2021-2032) Figure 38. Global Atezolizumab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Atezolizumab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Atezolizumab Revenue Market Share by Application (2021-2032) Figure 41. Global Atezolizumab Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 42. Global Atezolizumab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Atezolizumab Sales Market Share by Application (2021-2032) Figure 44. North America Atezolizumab Revenue Share by Type (2021-2032) Figure 45. North America Atezolizumab Sales Share by Type (2021-2032) Figure 46. North America Atezolizumab Revenue Share by Application (2021-2032) Figure 47. North America Atezolizumab Sales Share by Application (2021-2032) Figure 48. North America Atezolizumab Revenue Share by Country (2021-2032) Figure 49. North America Atezolizumab Sales Share by Country (2021-2032) Figure 50. Europe Atezolizumab Revenue Share by Type (2021-2032) Figure 51. Europe Atezolizumab Sales Share by Type (2021-2032) Figure 52. Europe Atezolizumab Revenue Share by Application (2021-2032) Figure 53. Europe Atezolizumab Sales Share by Application (2021-2032) Figure 54. Europe Atezolizumab Revenue Share by Country (2021-2032) Figure 55. Europe Atezolizumab Sales Share by Country (2021-2032) Figure 56. China Atezolizumab Revenue Share by Type (2021-2032) Figure 57. China Atezolizumab Sales Share by Type (2021-2032) Figure 58. China Atezolizumab Revenue Share by Application (2021-2032) Figure 59. China Atezolizumab Sales Share by Application (2021-2032) Figure 60. Asia Atezolizumab Revenue Share by Type (2021-2032) Figure 61. Asia Atezolizumab Sales Share by Type (2021-2032) Figure 62. Asia Atezolizumab Revenue Share by Application (2021-2032) Figure 63. Asia Atezolizumab Sales Share by Application (2021-2032) Figure 64. Asia Atezolizumab Revenue Share by Country (2021-2032) Figure 65. Asia Atezolizumab Sales Share by Country (2021-2032) Figure 66. SAMEA Atezolizumab Revenue Share by Type (2021-2032) Figure 67. SAMEA Atezolizumab Sales Share by Type (2021-2032) Figure 68. SAMEA Atezolizumab Revenue Share by Application (2021-2032) Figure 69. SAMEA Atezolizumab Sales Share by Application (2021-2032) Figure 70. SAMEA Atezolizumab Revenue Share by Country (2021-2032) Figure 71. SAMEA Atezolizumab Sales Share by Country (2021-2032) Figure 72. Atezolizumab Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Atezolizumab Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Use: Single Drug
  • Use: ChemOthersapy Combination
Applications
  • Advanced Triple-negative Breast Cancer
  • Head and Neck Cancer
  • Renal Cell Carcinoma
  • Urothelial Carcinoma
  • Hepatocellular Carcinoma (HCC)
  • Lung Cancer
  • Bladder Cancer
  • Others
Companies covered
  • Genentech (Roche)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Atezolizumab Market by Type
  3. 1.2.1 Global Atezolizumab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Use: Single Drug
  5. 1.2.3 Use: ChemOthersapy Combination
  6. 1.3 Atezolizumab Market by Application
  7. 1.3.1 Global Atezolizumab Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Advanced Triple-negative Breast Cancer
  9. 1.3.3 Head and Neck Cancer
  10. 1.3.4 Renal Cell Carcinoma
  11. 1.3.5 Urothelial Carcinoma
  12. 1.3.6 Hepatocellular Carcinoma (HCC)
  13. 1.3.7 Lung Cancer
  14. 1.3.8 Bladder Cancer
  15. 1.3.9 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Atezolizumab Market Dynamics
  1. 2.1 Atezolizumab Industry Trends
  2. 2.2 Atezolizumab Industry Drivers
  3. 2.3 Atezolizumab Industry Opportunities and Challenges
  4. 2.4 Atezolizumab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Atezolizumab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Atezolizumab Revenue by Region
  3. 3.2.1 Global Atezolizumab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Atezolizumab Revenue by Region (2021-2026)
  5. 3.2.3 Global Atezolizumab Revenue by Region (2027-2032)
  6. 3.2.4 Global Atezolizumab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Atezolizumab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Atezolizumab Sales by Region
  9. 3.4.1 Global Atezolizumab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Atezolizumab Sales by Region (2021-2026)
  11. 3.4.3 Global Atezolizumab Sales by Region (2027-2032)
  12. 3.4.4 Global Atezolizumab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Atezolizumab Revenue by Manufacturers
  2. 4.1.1 Global Atezolizumab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Atezolizumab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Atezolizumab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Atezolizumab Sales by Manufacturers
  6. 4.2.1 Global Atezolizumab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Atezolizumab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Atezolizumab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Atezolizumab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Atezolizumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Atezolizumab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Atezolizumab Manufacturers, Product Type & Application
  13. 4.7 Global Atezolizumab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Atezolizumab Market CR5 and HHI
  16. 4.8.2 2025 Atezolizumab Tier 1, Tier 2, and Tier 3
5 Atezolizumab Market by Type
  1. 5.1 Global Atezolizumab Revenue by Type
  2. 5.1.1 Global Atezolizumab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Atezolizumab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Atezolizumab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Atezolizumab Sales by Type
  6. 5.2.1 Global Atezolizumab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atezolizumab Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Atezolizumab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Atezolizumab Price by Type
6 Atezolizumab Market by Application
  1. 6.1 Global Atezolizumab Revenue by Application
  2. 6.1.1 Global Atezolizumab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Atezolizumab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Atezolizumab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Atezolizumab Sales by Application
  6. 6.2.1 Global Atezolizumab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Atezolizumab Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Atezolizumab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Atezolizumab Price by Application
7 Company Profiles
  1. 7.1 Genentech (Roche)
  2. 7.1.1 Genentech (Roche) Company Information
  3. 7.1.2 Genentech (Roche) Business Overview
  4. 7.1.3 Genentech (Roche) Atezolizumab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Genentech (Roche) Atezolizumab Product Portfolio
  6. 7.1.5 Genentech (Roche) Recent Developments
8 North America
  1. 8.1 North America Atezolizumab Market Size by Type
  2. 8.1.1 North America Atezolizumab Revenue by Type (2021-2032)
  3. 8.1.2 North America Atezolizumab Sales by Type (2021-2032)
  4. 8.1.3 North America Atezolizumab Price by Type (2021-2032)
  5. 8.2 North America Atezolizumab Market Size by Application
  6. 8.2.1 North America Atezolizumab Revenue by Application (2021-2032)
  7. 8.2.2 North America Atezolizumab Sales by Application (2021-2032)
  8. 8.2.3 North America Atezolizumab Price by Application (2021-2032)
  9. 8.3 North America Atezolizumab Market Size by Country
  10. 8.3.1 North America Atezolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Atezolizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Atezolizumab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Atezolizumab Market Size by Type
  2. 9.1.1 Europe Atezolizumab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Atezolizumab Sales by Type (2021-2032)
  4. 9.1.3 Europe Atezolizumab Price by Type (2021-2032)
  5. 9.2 Europe Atezolizumab Market Size by Application
  6. 9.2.1 Europe Atezolizumab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Atezolizumab Sales by Application (2021-2032)
  8. 9.2.3 Europe Atezolizumab Price by Application (2021-2032)
  9. 9.3 Europe Atezolizumab Market Size by Country
  10. 9.3.1 Europe Atezolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Atezolizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Atezolizumab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Atezolizumab Market Size by Type
  2. 10.1.1 China Atezolizumab Revenue by Type (2021-2032)
  3. 10.1.2 China Atezolizumab Sales by Type (2021-2032)
  4. 10.1.3 China Atezolizumab Price by Type (2021-2032)
  5. 10.2 China Atezolizumab Market Size by Application
  6. 10.2.1 China Atezolizumab Revenue by Application (2021-2032)
  7. 10.2.2 China Atezolizumab Sales by Application (2021-2032)
  8. 10.2.3 China Atezolizumab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Atezolizumab Market Size by Type
  2. 11.1.1 Asia Atezolizumab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Atezolizumab Sales by Type (2021-2032)
  4. 11.1.3 Asia Atezolizumab Price by Type (2021-2032)
  5. 11.2 Asia Atezolizumab Market Size by Application
  6. 11.2.1 Asia Atezolizumab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Atezolizumab Sales by Application (2021-2032)
  8. 11.2.3 Asia Atezolizumab Price by Application (2021-2032)
  9. 11.3 Asia Atezolizumab Market Size by Country
  10. 11.3.1 Asia Atezolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Atezolizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Atezolizumab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Atezolizumab Market Size by Type
  2. 12.1.1 SAMEA Atezolizumab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Atezolizumab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Atezolizumab Price by Type (2021-2032)
  5. 12.2 SAMEA Atezolizumab Market Size by Application
  6. 12.2.1 SAMEA Atezolizumab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Atezolizumab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Atezolizumab Price by Application (2021-2032)
  9. 12.3 SAMEA Atezolizumab Market Size by Country
  10. 12.3.1 SAMEA Atezolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Atezolizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Atezolizumab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Atezolizumab Value Chain Analysis
  2. 13.1.1 Atezolizumab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Atezolizumab Production Mode & Process
  6. 13.2 Atezolizumab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Atezolizumab Distributors
  9. 13.2.3 Atezolizumab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst